Evidence map›Paper›PMID 17475657›Full record

ArticleJournal of virology2007

Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase.

J David Beckham, Robin J Goody, Penny Clarke, Christophe Bonny, Kenneth L Tyler

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Cell Killing by Reovirus: Mechanisms and Consequences.Current topics in microbiology and immunology · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

J David BeckhamDepartment of Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA.
Robin J Goody
Penny Clarke
Christophe Bonny
Kenneth L Tyler
Neurology, Inc · USXigen (Switzerland) · CH

Funding

Mechanisms of Apoptosis in the central nervous systemR01NS050138 · NINDS · UNIVERSITY OF COLORADO DENVER · PI TYLER, KENNETH L. · 2005 to 2009
$1.3M
Molecular Basis of Microbial PathogenesisT32AI007537 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, RANDALL K · 1998 to 2007
$1.3M
Mechanisms of virus-induced apoptosis in neurons and CNSR01NS051403 · NINDS · UNIVERSITY OF COLORADO DENVER · PI TYLER, KENNETH L. · 2006 to 2010
$1.2M
Mechanisms of Apoptosis in Virus-Infected NeuronsK08AI076518 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BECKHAM, JOHN DAVID · 2008 to 2012
$801k
NIAID NIH HHS T32 AI007537NIAID NIH HHS T32AI07537NINDS NIH HHS 1R01NS051403NINDS NIH HHS 5R01NS050138NINDS NIH HHS R01 NS050138NINDS NIH HHS R01 NS051403
6 · The paper itself

Abstract

Viral encephalitis is a major cause of morbidity and mortality worldwide, yet there is no proven efficacious therapy for most viral infections of the central nervous system (CNS). Many of the viruses that cause encephalitis induce apoptosis and activate c-Jun N-terminal kinase (JNK) following infection. We have previously shown that reovirus infection of epithelial cell lines activates JNK-dependent apoptosis. We now show that reovirus infection resulted in activation of JNK and caspase-3 in the CNS. Treatment of reovirus-infected mice with a cell-permeating peptide that competitively inhibits JNK activity resulted in significantly prolonged survival of intracerebrally infected mice following an otherwise lethal challenge with T3D (100 x 50% lethal dose). Protection correlated with reduced CNS injury, reduced neuronal apoptosis, and reduced c-Jun activation without altering the viral titer or viral antigen distribution. Given the efficacy of the inhibitor in protecting mice from viral encephalitis, JNK inhibition represents a promising and novel treatment strategy for viral encephalitis.

Indexed as

AnimalsApoptosisCaspase 3Cell LineCentral Nervous SystemEncephalitis, ViralEnzyme InhibitorsHumansJNK Mitogen-Activated Protein KinasesMammalian orthoreovirus 3MiceNeuronsPeptidesReoviridae InfectionsCaspase 3Enzyme InhibitorsJNK Mitogen-Activated Protein KinasesPeptides

Identifiers

PMID17475657
PMCPMC1933289
OpenAlexW2058920907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.